-
1
-
-
0036916631
-
Heparin induced thrombocytopenia: A common complication in cardiac transplant recipients
-
Hourigan L.A., Walters D.L., Keck S.A., Dec G.W. Heparin induced thrombocytopenia a common complication in cardiac transplant recipients. J Heart Lung Transplant. 21:2002;1283-1289
-
(2002)
J Heart Lung Transplant
, vol.21
, pp. 1283-1289
-
-
Hourigan, L.A.1
Walters, D.L.2
Keck, S.A.3
Dec, G.W.4
-
2
-
-
0036213008
-
Heparin-induced thrombocytopenia: An overview
-
Kelton J.G. Heparin-induced thrombocytopenia an overview. Blood Rev. 16:2002;77-80
-
(2002)
Blood Rev
, vol.16
, pp. 77-80
-
-
Kelton, J.G.1
-
3
-
-
0034866893
-
Heparin-induced thrombocytopenia: Natural history diagnosis, and management
-
Deitcher S.R., Carman T.L. Heparin-induced thrombocytopenia natural history diagnosis, and management. Vasc Med. 6:2001;113-119
-
(2001)
Vasc Med
, vol.6
, pp. 113-119
-
-
Deitcher, S.R.1
Carman, T.L.2
-
4
-
-
0036301759
-
Heparin-induced thrombocytopenia: Temporal pattern of thrombocytopenia in relation initial use or reexposure to heparin
-
Lubenow N., Kempf R., Eichner A., Eichler P., Carlsson L.E., Greinacher A. Heparin-induced thrombocytopenia temporal pattern of thrombocytopenia in relation initial use or reexposure to heparin. Chest. 122:2002;37-42
-
(2002)
Chest
, vol.122
, pp. 37-42
-
-
Lubenow, N.1
Kempf, R.2
Eichner, A.3
Eichler, P.4
Carlsson, L.E.5
Greinacher, A.6
-
5
-
-
0036320729
-
Current agents for the treatment of patients with heparin-induced thrombocytopenia
-
Warkentin T.E. Current agents for the treatment of patients with heparin-induced thrombocytopenia. Curr Opin Pulmon Med. 8:2002;405-412
-
(2002)
Curr Opin Pulmon Med
, vol.8
, pp. 405-412
-
-
Warkentin, T.E.1
-
7
-
-
0035853125
-
Recombinant hirudin in clinical practice: Focus on lepirudin
-
Greinacher A., Lubenow N. Recombinant hirudin in clinical practice focus on lepirudin. Circulation. 103:2001;1479-1484
-
(2001)
Circulation
, vol.103
, pp. 1479-1484
-
-
Greinacher, A.1
Lubenow, N.2
-
8
-
-
0036771617
-
Fondaparinux (Arixtra) a new anticoagulant
-
Giamgrande P.L. Fondaparinux (Arixtra) a new anticoagulant. Int J Clin Pract. 56:2002;615-617
-
(2002)
Int J Clin Pract
, vol.56
, pp. 615-617
-
-
Giamgrande, P.L.1
-
9
-
-
0036034818
-
Danaparoid: A review of its use in thromboembolic and coagulation disorders
-
Ibbotson T., Perry C.M. Danaparoid a review of its use in thromboembolic and coagulation disorders. Drugs. 62:2002;2283-2314
-
(2002)
Drugs
, vol.62
, pp. 2283-2314
-
-
Ibbotson, T.1
Perry, C.M.2
-
10
-
-
0028014541
-
Heparin-associated thrombocytopenia: Isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen
-
Greinacher A., Potzsch B., Amiral J., Dummel V., Eicher A., Mueller-Eckhardt C. Heparin-associated thrombocytopenia isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen. Thromb Haemost. 71:1994;247-251
-
(1994)
Thromb Haemost
, vol.71
, pp. 247-251
-
-
Greinacher, A.1
Potzsch, B.2
Amiral, J.3
Dummel, V.4
Eicher, A.5
Mueller-Eckhardt, C.6
-
11
-
-
0034235401
-
Morphological analysis of microparticle generation in heparin-induced thrombocytopenia
-
Hughes M., Hayward C.P., Warkentin T.E., Horsewood P., Chorneyko K.A., Kelton J.G. Morphological analysis of microparticle generation in heparin-induced thrombocytopenia. Blood. 96:2000;188-194
-
(2000)
Blood
, vol.96
, pp. 188-194
-
-
Hughes, M.1
Hayward, C.P.2
Warkentin, T.E.3
Horsewood, P.4
Chorneyko, K.A.5
Kelton, J.G.6
-
12
-
-
0034091906
-
Clinical application of argatroban as an alternative anticoagulant for extracorporeal circulation
-
Kawada T., Kitagawa H., Hoson M., Okada Y., Shiomura J. Clinical application of argatroban as an alternative anticoagulant for extracorporeal circulation. Hematol Oncol Clin N Am. 14:2000;445-457
-
(2000)
Hematol Oncol Clin N Am
, vol.14
, pp. 445-457
-
-
Kawada, T.1
Kitagawa, H.2
Hoson, M.3
Okada, Y.4
Shiomura, J.5
-
13
-
-
0033631076
-
Clinical experience of Argatroban for anticoagulation in cardiovascular surgery
-
Ohteki H., Furukawa K., Ohnishi H., Narita Y., Sakai M., Doi K. Clinical experience of Argatroban for anticoagulation in cardiovascular surgery. Jpn J Thorac Cardiovasc Surg. 48:2000;39-46
-
(2000)
Jpn J Thorac Cardiovasc Surg
, vol.48
, pp. 39-46
-
-
Ohteki, H.1
Furukawa, K.2
Ohnishi, H.3
Narita, Y.4
Sakai, M.5
Doi, K.6
-
14
-
-
0034741623
-
Alternatives to unfractionated heparin for anticoagulation in cardiopulmonary bypass
-
von Segesser L.K., Mueller X., Marty B., Horisberger J., Corno A. Alternatives to unfractionated heparin for anticoagulation in cardiopulmonary bypass. Perfusion. 16:2001;411-416
-
(2001)
Perfusion
, vol.16
, pp. 411-416
-
-
Von Segesser, L.K.1
Mueller, X.2
Marty, B.3
Horisberger, J.4
Corno, A.5
-
15
-
-
0035783623
-
The use of argatroban as an anticoagulation for cardiopulmonary bypass in cardiac operations
-
Furukawa K., Ohteki H., Hirahara K., et al. The use of argatroban as an anticoagulation for cardiopulmonary bypass in cardiac operations. J Thorac Cardiovasc Surg. 122:2001;1255-1256
-
(2001)
J Thorac Cardiovasc Surg
, vol.122
, pp. 1255-1256
-
-
Furukawa, K.1
Ohteki, H.2
Hirahara, K.3
-
16
-
-
0036212053
-
Removal of lepirudin, a recombinant hirudin, by hemodialysis, hemofiltration, or plasmapheresis
-
Willet M.L., de Denus S., Spinler S.A. Removal of lepirudin, a recombinant hirudin, by hemodialysis, hemofiltration, or plasmapheresis. Pharmacotherapy. 22:2002;492-499
-
(2002)
Pharmacotherapy
, vol.22
, pp. 492-499
-
-
Willet, M.L.1
De Denus, S.2
Spinler, S.A.3
-
17
-
-
0035983918
-
Bivalirudin pharmacokinetics and pharmacodynamics: Effect of renal function, dose, and gender
-
Robson R., White H., Aylward P., Frampton C. Bivalirudin pharmacokinetics and pharmacodynamics effect of renal function, dose, and gender. Clin Pharmacol Ther. 71:2002;433-439
-
(2002)
Clin Pharmacol Ther
, vol.71
, pp. 433-439
-
-
Robson, R.1
White, H.2
Aylward, P.3
Frampton, C.4
-
18
-
-
0027209030
-
Use of a direct antithrombin, hirulog, in place of heparin during coronary angioplasty
-
Ferguson D.J., Willerson J.T., Strony J., et al. Use of a direct antithrombin, hirulog, in place of heparin during coronary angioplasty. Circulation. 87:1993;1622-1629
-
(1993)
Circulation
, vol.87
, pp. 1622-1629
-
-
Ferguson, D.J.1
Willerson, J.T.2
Strony, J.3
|